Autoantibodies targeting the cytosolic 5’-nucleotidase 1A (cN1A) were frequently identified in patients with inclusion body myositis and have been expected to be a serological marker for early diagnosis [41]. This evidence concerns the gene NT5C1A and inclusion body myositis.